B03XA01 • epoetin alfa • Blood and blood forming organs | Other antianemic preparations
Epoetin alfa is a medication used to treat anemia, especially in patients with chronic kidney failure or those undergoing chemotherapy for cancer. This medicine stimulates the bone marrow to produce more red blood cells, helping to increase hemoglobin levels and reduce symptoms of fatigue. It is usually administered by subcutaneous or intravenous injection, as recommended by the doctor.
During treatment with epoetin alfa, close monitoring of hemoglobin levels and dose adjustments are necessary to prevent complications. Patients should follow the schedule for blood tests and report any new or unusual symptoms to their doctor.
Side effects may include increased blood pressure, headaches, muscle pain, or reactions at the injection site. In rare cases, severe allergic reactions or an increased risk of blood clots may occur.
Epoetin alfa is an important treatment for patients with severe anemia, but it requires constant medical supervision to ensure the therapy's effectiveness and safety. Close collaboration with the medical team is essential for treatment success.
Substance: epoetin alfa
Date of last drug list: 01-07-2013
Commercial code: W52277001
Concentration: 4000UI / 0.4ml
Pharmaceutical form: solution for injection in pre-filled syringe
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).